Each year, approximately 250,000 Germans suffer a stroke. This makes stroke the third leading cause of death after heart disease and cancer. The circulatory disorder that occurs in the brain is normally treated using systemic thrombolysis, a procedure that bears various risks. Unlike mechanical thrombectomy, which offers clear advantages by comparison.
Multiple sclerosis apparently can strike anyone - regardless of age, family history, lifestyle or gender. Yet why then does it not strike everyone? Genetic and environmental factors appear not to be the only reason whether it develops or not. The countless microorganisms that colonize our intestinal tract could also be involved in this.
If you could stimulate brain cells to grow in a specific direction, you would probably be able to achieve a significant improvement in the health of patients suffering from Parkinson’s disease. This is why the MAGNEURON project focuses on this approach. Biophysicist Professor Jacob Piehler of the University of Osnabrück has also done research in this field.